• 제목/요약/키워드: albumin.

검색결과 2,368건 처리시간 0.031초

Urinary albumin excretion rate and puberty in non-diabetic children and adolescents

  • Bangstad H.J.;Jorgensen K. Dahl;Kjaersgaard P.;Mevold K.;Hanssen K.F.
    • 대한예방의학회:학술대회논문집
    • /
    • 대한예방의학회 1994년도 교수 연수회(역학)
    • /
    • pp.158-163
    • /
    • 1994
  • Slightly elevated urinary albumin excretion rate (microalhuminuria) is a marker of early diabectic nephropathy, but it is unclear if the established definition of microalbuminuria ($20-200{\mu}g/min$) is correct for children and adolescents. We investigated th.: albumin excretion rate, albumin/creatinine ratio and urinary albumin concentration in 150 healthy schoolchildren and adolescents to (a) obtain a reterence value for albumin excretion rate, (b) relate albumin excretion to pubertal stages and (c) evaluate albumin/creatinine ratio and morning albumin concentration as screening methods for elevated albumin excretion rate. Albumin concentration was measured by immunoturbidimetry in timed overnight urine samples. The albumin excretion showed a skewed distribution (geometric mean $3.2{\mu}g/min$, 95 percentile ($15.1{\mu}g/min$). In girls. a peak in the albumin excretion rate was found at the pubertal stage 4 (Tanner) and in boys at stage 5. Albumin/creatinine ratio of 2.5 mg/mmol as a screening level for elevated albumin excretion ($15{\mu}g/min$) showed a high positive (0.88) and negative (0.99) predictive value.

  • PDF

Prenatal effect of pyrantel pamoate on several hematological parameter of offspring in mice

  • Abdulwahab.A.Noorwall;Ghazi M. Al-Hachim;Award -Omar
    • Archives of Pharmacal Research
    • /
    • 제9권2호
    • /
    • pp.87-91
    • /
    • 1986
  • In attempt to develop a drug delivery system using serum albumin microspheres, bovine serum albumin microspheres containing antitumar agent. Cytarabine, were prepared. The shape, surface characteristics, size distribution, behavior of in vivo distribution, drug release behavior, and degradation of albumin microsphers in animal liver issue homogenate and proteolytic enzyme were investigated. The shape of albumin microspheres was spherical and the surface was smooth and compact. The size distribution of the albumin microspheres was effected by dispertion forces during emulsification and albumin concentration. Distribution of albumin microspheres after imtravenous administration in rabbit was achieved immediately. In vitro, albumin microsphere matrix was so hard that it retained most of cytarabine except initial burst during the first 10 minutes, and the level of drug release during the initial burst was affected by heating temperature, drug/albumin microsphere matrix was so hard that it retained most of cytarabine except initial burst during the first 10 minutes, and the level of drug release during the initial burst was affected by heating temperature, drug/albumin concentration ratio and size distribution. After drug release test, the morphology of albumin microspheres was not changed. Albumin microsphere matrix was degraded by the animal liver issue homogenate and proteolytic enzyme. The degree of degradation was affected by heating temperature.

  • PDF

Development of specific organ-targeting drug delivery system 1

  • Kim, Chong-Kook;Jeong, Eun-Ju;Yang, Ji-Sun;Kim, Seung-Hwan;Kim, Yang-Bae
    • Archives of Pharmacal Research
    • /
    • 제8권3호
    • /
    • pp.159-168
    • /
    • 1985
  • In attempt to develop a drug delivery system using serum albumin microspheres, bovine serum albumin microspheres containing antitumor agent, cytarabine, were prepared. The shape, surface characteristics, size distribution, behavior of in vitro distribution, drug release behaior, and degradation of albumin microspheres in animal liver tissue homogenate and proteolytic enzyme were investigated. The shape of albumin microspheres was spherical and the surface was smooth and compact. The size distribution of the albumin microspheres was affected by dispersion forces during emulsification and albumin concentration. Distribution of albumin mirospheres after intravenous administration in rabbit was achieved immediately. In vitro, albumin microsphere matrix was so hard that it retained most of cytarabine except initial burst during the first 10 minutes, and the level of drug release during the initial burst was affected by heating temperature, drug/albumin concentration ratio and size distribution. After drug release test, the morphology of albumin micropheres was not changed. Albumin microsphere matrix was degraded by the rabbit liver tissue homogenate and proteolytic enzyme. The degree of degradation was affected by heating temperature.

  • PDF

Development of Specific organ targeting drug delivery system II : Physico-pharaceutical study on the crose-linked albumin microspheres containing cytarabine

  • Kim, Chong-Kook;Lee, Jin-Kyu;Lah, Woon-Lyong
    • Archives of Pharmacal Research
    • /
    • 제9권1호
    • /
    • pp.39-43
    • /
    • 1986
  • Bovine serum albumin microspheres containing cytarabine were prepared using cross-linking agent, formaldehyde. The shape and the size distribution of them were observed. The shape of them was spherical and the susrface was compact and smooth. The size distribution of them was affected by dispersion forces during emulsfication. The release of cytarabine from albumin microspheres was dependent upon cross-linking time, amount of cross-linking agent and drug/albumin ratio. However, the difference of drug release by the dispersion forces was not great. After release test, the shape of albumin microspheres was nonspherical and the albumin matrix seemed to be a little relaxed. The degradation tests of albumin microspheres by the proteolytic enzyme showed that albumin microspheres were progressively digested according to the cross-linking degree.

  • PDF

Egg Albumin이 알콜생산의 증진에 미치는 영향 및 기능 (Enhancing Effect of Egg Albumin on Ethanol Production and Its Function)

  • 김흥선;신철수
    • KSBB Journal
    • /
    • 제5권4호
    • /
    • pp.373-376
    • /
    • 1990
  • Saccharomyces sake를 이용한 알콜발효에서 배지의 첨가물로 egg albumin 및 phoshatidylcholine이 최종 알콜 농도에 미치는 영향과 그의 기작에 대햐여 분석하였다. Phosphatidycholine-egg albumin이 첨가될 때 최종 알콜 농도는 120g / l 정도 얻어졌으며, 첨가물이없는 경우에 비해 대략 30% 정도, 첨가물 linoleic acid-ergosterol에 비하여 20% 정도 증가되었다. 최종 알콜농도가 높을수록 균체의 알콜내성도 비례적으로 증가하였으며, 두 첨가물 사이의 차이는 지방산보다는 albumin과 ergosterol의 영향으로부터 주로 비롯되었다. 열반성 혹은 가수분해된 albumin을 첨가한 결과로 부터 albumin은 균체외부에 보호막을 형성하기보다는 영양분으로 균체내에 흡수되어 균체성질을 변화시켜 알콜내성을 증진시키며, 이로부터 궁극적으로 최종 알콜 농도를 증가시키는 것으로 판단되었다.

  • PDF

Parenteral Formulations Based on Albumin Particulate Technology

  • Lee, Hong-Hwa;Lee, Min-Jung;Heo, Sun-Ju;Sah, Hong-Kee
    • Journal of Pharmaceutical Investigation
    • /
    • 제40권spc호
    • /
    • pp.83-95
    • /
    • 2010
  • Over the years, nanoparticle drug delivery systems have demonstrated versatile potentials in biological, medical and pharmaceutical applications. In the pharmaceutical industry nanotechnology research has mainly focused on providing controlled drug release, targeting their delivery to specific organs, and developing parenteral formulations for poorly water soluble drugs to improve their bioavailability. Achievement in polymer industry has generated numerous polymers applicable to designing nanoparticles. From viewpoints of product development, a nanocarrier material should meet requirements for biodegradability, biocompatibility, availability, and regulatory approval crieteria. Albumin is indeed a material that fulfills such requirements. Also, the commercialization of a first albumin-bound paclitaxel nanoparticle product (Abraxane$^{TM}$) has sparked renewed interests in the application of albumin in the development of nanoparticle formulations. This paper reviews the intrinsic properties of albumin, its suitability as a nanocarrier material, and albumin-based parenteral formulation approaches. Particularly discussed in detail are albumin-based particulate injectables such as Abraxane$^{TM}$. Information on key roles of albumin in the nab$^{TM}$ technology and representative manufacturing processes of albumin particulate products are provided. It is likely that albumin-based particulate technology would extend its applications in delivering drugs, polypeptides, proteins, vaccines, nucleic acids, and genes.

포유류 혈장알부민의 이질성 (Heterogeneity of Mammalian Plasma Albumin)

  • Kim, Sang-Yeop;Park, Sang-Yoon
    • 한국동물학회지
    • /
    • 제25권3호
    • /
    • pp.115-122
    • /
    • 1982
  • 소의 혈장으로부터 알부민을 순수 정제하였으며 순도는 면역 화학적 방법을 사용하여 확인하였다. 정제된 알부민에 maleate, iodoacetate, iodoacetamide 및 glutathione의 4가지 thiol 화합물을 각각 반응시켜 그 복합체를 9가지의 상이한 완충용액내에서 초산셀룰로우즈 전기영동한 결과 barbital buffer와 Na-acetate buffer를 제외한 다른 완충용액내에서 albumin-glutathione 복합체는 두 가지의 단백질로 분리되었으며 pH 4.8 citrate buffer 및 pH 4.8 succinate buffer내에서 albumin-iodoacetate 및 albumin-iodoacetamide 복합체는 두 가지의 단백질로 분리되었다. 전기영동상에 나타나는 알부민 분획에는 conformation이 서로 다른 두 가지 이상의 알부민 분자가 존재한다고 사료된다.

  • PDF

정자의 수정능력획득 과정 동안 정자표면의 Albumin의 이탈현상 (Loss of Surface-Associated Albumin during Capacitation and Acrosome Reaction of Mouse Epididymal Sperm in vitro)

  • 계명찬;김문규
    • 한국동물학회지
    • /
    • 제38권4호
    • /
    • pp.514-522
    • /
    • 1995
  • 생쥐 정자의 수정능력 획득과정 및 첨체반응을 전후로 정자표면과 albumin의 상호작용을 조사하였다. 부정소 정자를 체외에서 배양하는 과정에서 정자표면에서 이탈된 단백질의 분석과 함께 FITC-bovine serum albumin으로 정자를 형광염색하여 정자표면에 대한 albumin의 결합양상의 변화를 조사하였다. 90분간 정자를 배양한 수 정자를 제거한 후 농축한 배양액내에 정자 또는 부정소액에서 기원한 여러종의 단백질가 함께 albumin이 다량으로 발견되었다 정자의 체외배양 과정에서 일어나는 albumin의 이탈은 배양액내의 $Ca^2$+과 무관하게 일어났다. BSA-FITC는 정소내 정자의 두부표면에 미약하게 결합한 반면 미부부정소 정자의 첨체표면에는 다량 결합하였다. $Ca^2$+-ionophore인 A23187으로 첨체반응을 유발한 정자의 두부 표면에서는 후첨체부위만이 강하게 염색되었다. 이러한 결과는 정소 및 웅성 생식수관니에서 정자표면에 부착된 albumin이 자성 생식수관을 거치는 동안 이탈됨을 시사하며 이러한 현상은 정자의 수정능력획득과 밀접한 관련이 있는 것으로 사료된다.

  • PDF

Simple Coacervation에 의한 Beads 및 Sulfamethoxydiazine의 Albumin Microcapsule의 조제에 관한 연구 (Preparation of Albumin Microcapsule Containing Beads and Sulfamethoxydiazine by Simple Coacervation)

  • 구영순;김신옥
    • 약학회지
    • /
    • 제31권3호
    • /
    • pp.182-188
    • /
    • 1987
  • Simple coacervation of bovine serum albumin was studied to prepare biodegradable microacapsule. Albumin microcapsules were prepared by using acrylonitrilestyrene polymer (M-80) resin beads and sulfamethoxydiazine as the core materials. The albumin to beads ratio was found to be 1:2.3 and the albumin to sulfamethoxydiazine ratio to be 1:2.9. The 50% release times (T$_{50%}$) of sulfamethoxydiazine and microencapsulated sulfamethoxydiazine were 6 min. and 73 min., respectively. The surface appearance of the microcapsule collected after release experiment was not different from those of the original microcapsule. In addition to slowing release of drug the microencapsulation process masked characteristic bitter taste of sulfamethoxydiazine.

  • PDF

Human Serum Albumin이 Estrogen과 기타 Ligands와의 결합력에 관한 연구 (Binding Capacity of Human Serum Albumin with Estrogen and Other Ligands)

  • Park, Geum-Soon
    • 한국식품영양과학회지
    • /
    • 제23권3호
    • /
    • pp.414-419
    • /
    • 1994
  • This study was trying to find what physical changes occurred to albumin when it reacted with estrogen and other ligands. Each concentration of human serum albumin with 100$\mu$l estradiol reacted at the highest binding capacity of 280nm. In addition, 1 hr of reaction time showed the highest binding rate. Conformational changes in human serum albumin with dietylstillbesterol and N-ethyl-maleimide produced strong binding capacities. The changes were immediate and they did not increase or decrease over time. Effects of human serum albumin with estriol induced no interaction each other. The binding capacity of human serum albumin with vitamin D$_2$was lower than estradiol. and the highest binding rate showed 1 hr of reaction time. Vitamin D$_2$ was very similar to the binding capacity of estradiol.

  • PDF